Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms
Status:
Unknown status
Trial end date:
2020-03-31
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, open Label, add-on study.
Phase:
N/A
Details
Lead Sponsor:
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Collaborators:
Beijing Luhe Hospital Cangzhou People's Hospital Qingdao Municipal Hospital the first affiliated hospital of Liaoning university of traditional Chinese medicine The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine